Dynavax Technologies | 销售和管理费用

Name: Dynavax Technologies | 销售和管理费用
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

	Selling And Administration Expenses		日
Adma Biologics	USD 16.22M	1.03M	2023-12
AstraZeneca	USD 3.91B	194M	2023-09
Gilead Sciences	USD 1.61B	293M	2023-12
Roche Holding	CHF 6.51B	26M	2023-06

Dynavax Technologies 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.